Epidemiology and outcome of nosocomial and community-onset bloodstream infection

被引:237
作者
Diekema, DJ
Beekmann, SE
Chapin, KC
Morel, KA
Munson, E
Doern, GV
机构
[1] Roy J & Lucille A Carver Univ Iowa, Coll Med, Div Infect Dis, Dept Internal Med, Iowa City, IA USA
[2] Roy J & Lucille A Carver Univ Iowa, Coll Med, Div Med Microbiol, Dept Pathol, Iowa City, IA USA
[3] Lahey Clin Fdn, Dept Pathol, Div Med Microbiol, Burlington, MA USA
关键词
D O I
10.1128/JCM.41.8.3655-3660.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We performed a prospective study of bloodstream infection to determine factors independently associated with mortality. Between February 1999 and July 2000, 929 consecutive episodes of bloodstream infection at two tertiary care centers were studied. An ICD-9-based Charlson Index was used to adjust for underlying illness. Crude mortality was 24% (14% for community-onset versus 34% for nosocomial bloodstream infections). Mortality attributed to the bloodstream infection was 17% overall (10% for community-onset versus 23% for nosocomial bloodstream infections). Multivariate logistic regression revealed the independent associations with in-hospital mortality to be as follows: nosocomial acquisition (odds ratio [OR.] 2.6, P < 0.0001), hypotension (OR 2.6, P < 0.0001), absence of a febrile response (P = 0.003), tachypnea (OR 1.9, P = 0.001), leukopenia or leukocytosis (total white blood cell count of <4,500 or >20,000, P = 0.003), presence of a central venous catheter (OR 2.0, P = 0.0002), and presence of anaerobic organism (OR 2.5, P = 0.04). Even after adjustments were made for underlying illness and length of stay, nosocomial status of bloodstream infection was strongly associated with increased total hospital charges (P < 0.0001). Although accounting for about half of all bloodstream infections, nosocomial bloodstream infections account for most of the mortality and costs associated with bloodstream infection.
引用
收藏
页码:3655 / 3660
页数:6
相关论文
共 26 条
[1]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[2]   FACTORS AFFECTING MORTALITY OF GRAM-NEGATIVE ROD BACTEREMIA [J].
BRYANT, RE ;
HOOD, AF ;
HOOD, CE ;
KOENIG, MG .
ARCHIVES OF INTERNAL MEDICINE, 1971, 127 (01) :120-&
[3]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   A comparison of two antimicrobial-impregnated central venous catheters [J].
Darouiche, RO ;
Raad, II ;
Heard, SO ;
Thornby, JI ;
Wenker, OC ;
Gabrielli, A ;
Berg, J ;
Khardori, N ;
Hanna, H ;
Hachem, R ;
Harris, RL ;
Mayhall, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :1-8
[6]   Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America [J].
Diekema, DJ ;
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Kugler, KC ;
Beach, ML ;
Sader, HS .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) :257-271
[7]   Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].
Edmond, MB ;
Wallace, SE ;
McClish, DK ;
Pfaller, MA ;
Jones, RN ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244
[8]   Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].
Fridkin, SK ;
Steward, CD ;
Edwards, JR ;
Pryor, ER ;
McGowan, JE ;
Archibald, LK ;
Gaynes, RP ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252
[9]  
GAYNES RP, 1996, HOSP EPIDEMIOLOGY IN, P1017
[10]  
GOMEZ J, 1993, CLIN INVESTIGATOR, V71, P595